xianglin li

Prof. Dr. xianglin li


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2022 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
YLYijie Lv
Yijie Lv
JKJunnan Kan
Junnan Kan
MLMingfang Luo
Mingfang Luo
CYChangfeng Yang
Changfeng Yang
XLXunrong Luo
Xunrong Luo
XLxianglin li
xianglin li
Introduction: Accurate tumor diagnosis is essential to achieve the ideal therapeutic effect. However, it is difficult to accurately diagnose cancer using a single imaging method because of the technical limitations. Multimodal imaging plays an increasingly important role in tumor treatment. Photodynamic therapy (PDT) has received widespread attention in tumor treatment due to its high specificity and controllable photocytotoxicity. Nevertheless, PDT is susceptible to tumor microenvironment (TME) hypoxia, which greatly reduces the therapeutic effect of tumor treatment. Methods: In this study, a novel multifunctional nano-snowflake probe ([email protected]2@Ce6, UMC) for oxygen-enhanced photodynamic therapy was developed. We have fabricated the honeycomb-like MnO2 to co-load chlorin e6 (Ce6, a photosensitizer) and ultrasmall superparamagnetic iron oxide (USPIO, T1-T2 double contrast agent). Under the high H2O2 level of tumor cells, UMC efficiently degraded and triggered the exposure of photosensitizers to the generated oxygen, accelerating the production of reactive oxygen species (ROS) during PDT. Moreover, the resulting USPIO and Mn2+ allow for MR T1-T2 imaging and transformable PAI for multimodal imaging-guided tumor therapy. Results: TEM and UV-vis spectroscopy results showed that nano-snowflake probe (UMC) was successfully synthesized, and the degradation of UMC was due to the pH/ H2O2 responsive properties. In vitro results indicated good uptake of UMC in 4T-1 cells, with maximal accumulation at 4 h. In vitro and in vivo experimental results showed their imaging capability for both T1-T2 MR and PA imaging, providing the potential for multimodal imaging-guided tumor therapy. Compared to the free Ce6, UMC exhibited enhanced treatment efficiency due to the production of O2 with the assistance of 660 nm laser irradiation. In vivo experiments confirmed that UMC achieved oxygenated PDT under MR/PA imaging guidance in tumor-bearing mice and significantly inhibited tumor growth in tumor-bearing mice, exhibiting good biocompatibility and minimal side effects. Conclusion: The multimodal imaging contrast agent (UMC) not only can be used for MR and PA imaging but also has oxygen-enhanced PDT capabilities. These results suggest that UMC may have a good potential for further clinical application in the future. Graphical Abstract:

21 February 2022 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
MLMingfang Luo
Mingfang Luo
YLYijie Lv
Yijie Lv
XLXunrong Luo
Xunrong Luo
QRQingfa Ren
Qingfa Ren
ZSZhenbo Sun
Zhenbo Sun
XLxianglin li
xianglin li
With the development of nanotechnology, a theranostics nanoplatform can have broad applications in multimodal image-guided combination treatment in cancer precision medicine. To overcome the limitations of a single diagnostic imaging mode and a single chemotherapeutic approach, we intend to combat tumor growth and provide therapeutic interventions by integrating multimodal imaging capabilities and effective combination therapies on an advanced platform. So, we have constructed IO@MnO2@DOX (IMD) hybrid nanoparticles composed of superparamagnetic iron oxide (IO), manganese dioxide (MnO2), and doxorubicin (DOX). The nano-platform could achieve efficient T2-T1 magnetic resonance (MR) imaging, switchable photoacoustic (PA) imaging, and tumor microenvironment (TME)-responsive DOX release and achieve enhanced synergism of magnetic hyperthermia and chemotherapy with PA/MR bimodal imaging. The results show that IMD has excellent heating properties when exposed to an alternating magnetic field (AMF). Therefore, it can be used as an inducer for tumor synergism therapy with chemotherapy and hyperthermia. In the TME, the IMD nanoparticle was degraded, accompanied by DOX release. Moreover, in vivo experimental results show that the smart nanoparticles had excellent T2-T1 MR and PA imaging capabilities and an excellent synergistic effect of magnetic hyperthermia and chemotherapy. IMD nanoparticles could significantly inhibit tumor growth in tumor-bearing mice with negligible side effects. In conclusion, smart IMD nanoparticles have the potential for tumor diagnosis and growth inhibition as integrated diagnostic nanoprobes.

20 February 2023 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
ZZZhen Zeng
Zhen Zeng
YDYingying Dong
Yingying Dong
LZLinxuan Zou
Linxuan Zou
DXDonghao Xu
Donghao Xu
XLXunrong Luo
Xunrong Luo
XLxianglin li
xianglin li

12 July 2024 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
ZCZhenyu Cheng
Zhenyu Cheng
WNWenying Nie
Wenying Nie
JLJunhong Leng
Junhong Leng
LYLinfeng Yang
Linfeng Yang
YWYuanyuan Wang
Yuanyuan Wang
LGLingfei Guo
Lingfei Guo
Cerebral small vessel disease (CSVD) is a prevalent vascular disorder that has been consistently associated with vascular cognitive impairment (VCI). The diagnosis of CSVD continues to rely on magnetic resonance imaging (MRI). Epidemiological data indicate that the characteristic MRI features of CSVD, including white matter hyperintensity (WMH) and lacunar infarction, are very common among individuals over 40 years of age in community studies. This prevalence poses a significant burden on many low- and middle-income families. The amygdala plays a crucial role in integrating sensory and associative information to regulate emotional cognition. Although many previous studies have linked alterations in the amygdala to various diseases, such as depression, there has been little research on CSVD-associated alterations in the amygdala due to the complexity of CSVD. In this paper, we summarize the various imaging features of CSVD and discuss the correlation between amygdala changes and VCI. We also explore how new neuroimaging methods can assess amygdala changes early, laying a foundation for future comprehensive exploration of the pathogenesis of CSVD.

26 July 2023 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
HLHao Li
Hao Li
XLXunrong Luo
Xunrong Luo
KQKai Qi
Kai Qi
YLYijie Lv
Yijie Lv
JKJunnan Kan
Junnan Kan
XLxianglin li
xianglin li

13 February 2025 in Behavioural Brain Research
Verified
Journal Article
Closed access
MLMiaomiao Liu
Miaomiao Liu
MLMinglong Li
Minglong Li
HDHailing Du
Hailing Du
DXDonghao Xu
Donghao Xu
JWJing Wang
Jing Wang
QLQuanyuan Liu
Quanyuan Liu